The Therapeutic Effect Of Anticoagulants On The Acute Respiratory Distress Syndrome Rats

Jy Zhao,H Liu,Sj Wang

1998-01-01

Abstract:Acute respiratory distress syndrome (ARDS) is one of the most severe endings of irritant gas poisoning which is quire a common occupational injury in industrial accidents, the mortality is as high as 50% or more. Our primary study found by animal model that some hypercoagulability existed in pulmonary circulation of ARDS rats. For further exploration of the role of the hypercoagulation state in the pathogenesis of ARDS, some anticoagulant or thrombolytic drugs such as heparin, ahylysantinfarctase (snake venom antithrombotic enzyme, SVATE) and taurine were injected (i.v, or i.p) into the ARDS rats, the chemical agents in the study. The results showed that all these drugs had a good effect on ARDS: in the rats of drug-treated groups, the PAF (platelet-activating factor) activity in lung tissue and BALF decreased from 10.42 +/- 1.27 u to 12.24 +/- 0.69 u, and 12.52 +/- 0.67 u to 13.51 +/- 0.92 u, respectively (ARDS rats were 15.21 +/- 0.56 u and 15.73 +/- 0.37 u, respectively), PaO2 was kept at a higher level(>80 mmHg, ARDS rats were less than 60 mmHg), and the pathological changes also had obviously improved, particularly in the SVATE group, but heparin seemed to exacerbate the hemorrhage in the lung.The conclusion, therefore, is that the elimination of the hypercoagulation state in pulmonary circulation is probably the key to block the progress of ARDS, and that the anticoagulant or thrombolytic therapy is probably one of the most important methods in the treatment of ARDS.